These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15075520)

  • 1. Minor nef gene alterations after human HIV-DNA immunisation.
    Aleman S; Leitner T; Liu MA; Wahren B
    AIDS; 2004 Mar; 18(5):817-9. PubMed ID: 15075520
    [No Abstract]   [Full Text] [Related]  

  • 2. DNA vaccination in mice using HIV-1 nef, rev and tat genes in self-replicating pBN-vector.
    Tähtinen M; Strengell M; Collings A; Pitkänen J; Kjerrström A; Hakkarainen K; Peterson P; Kohleisen B; Wahren B; Ranki A; Ustav M; Krohn K
    Vaccine; 2001 Feb; 19(15-16):2039-47. PubMed ID: 11228375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene combination raises broad human immunodeficiency virus-specific cytotoxicity.
    Calarota SA; Kjerrström A; Islam KB; Wahren B
    Hum Gene Ther; 2001 Sep; 12(13):1623-37. PubMed ID: 11535166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleic acid vaccination with HIV regulatory genes.
    Wahren B; Hinkula J; Ståhle EL; Borrebaeck CA; Schwartz S; Wigzell H
    Ann N Y Acad Sci; 1995 Nov; 772():278-81. PubMed ID: 8546408
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design.
    Novitsky V; Rybak N; McLane MF; Gilbert P; Chigwedere P; Klein I; Gaolekwe S; Chang SY; Peter T; Thior I; Ndung'u T; Vannberg F; Foley BT; Marlink R; Lee TH; Essex M
    J Virol; 2001 Oct; 75(19):9210-28. PubMed ID: 11533184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionally-inactive and immunogenic Tat, Rev and Nef DNA vaccines derived from sub-Saharan subtype C human immunodeficiency virus type 1 consensus sequences.
    Scriba TJ; zur Megede J; Glashoff RH; Treurnicht FK; Barnett SW; van Rensburg EJ
    Vaccine; 2005 Jan; 23(9):1158-69. PubMed ID: 15629359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of single and combined human immunodeficiency virus type 1 (HIV-1) DNA vaccines.
    Kjerrström A; Hinkula J; Engström G; Ovod V; Krohn K; Benthin R; Wahren B
    Virology; 2001 May; 284(1):46-61. PubMed ID: 11352667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses in asymptomatic HIV-1-infected patients after HIV-DNA immunization followed by highly active antiretroviral treatment.
    Calarota SA; Leandersson AC; Bratt G; Hinkula J; Klinman DM; Weinhold KJ; Sandström E; Wahren B
    J Immunol; 1999 Aug; 163(4):2330-8. PubMed ID: 10438897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservation of cytotoxic T lymphocyte (CTL) epitopes as a host strategy to constrain parasite adaptation: evidence from the nef gene of human immunodeficiency virus 1 (HIV-1).
    da Silva J; Hughes AL
    Mol Biol Evol; 1998 Oct; 15(10):1259-68. PubMed ID: 9787432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the South African HIV type 1 subtype C complete 5' long terminal repeat, nef, and regulatory genes.
    Scriba TJ; de Villiers T; Treurnicht FK; zur Megede J; Barnett SW; Engelbrecht S; van Rensburg EJ
    AIDS Res Hum Retroviruses; 2002 Jan; 18(2):149-59. PubMed ID: 11839148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accurate and differential quantitation of HIV-1 tat, rev and nef mRNAs by competitive PCR.
    Merzouki A; Mo T; Vellani N; Pattullo A; Estable M; O'Shaughnessy M; Tsoukas C; Cassol S
    J Virol Methods; 1994 Dec; 50(1-3):115-28. PubMed ID: 7714034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response.
    MacGregor RR; Boyer JD; Ugen KE; Lacy KE; Gluckman SJ; Bagarazzi ML; Chattergoon MA; Baine Y; Higgins TJ; Ciccarelli RB; Coney LR; Ginsberg RS; Weiner DB
    J Infect Dis; 1998 Jul; 178(1):92-100. PubMed ID: 9652427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [HIV-1 nef specific cytotoxic T lymphocyte responses in long-term nonprogressors and AIDS patients].
    Zhang HW; Qiu ZF; Li TS
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(23):1973-6. PubMed ID: 15730808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial.
    Rolland M; Tovanabutra S; deCamp AC; Frahm N; Gilbert PB; Sanders-Buell E; Heath L; Magaret CA; Bose M; Bradfield A; O'Sullivan A; Crossler J; Jones T; Nau M; Wong K; Zhao H; Raugi DN; Sorensen S; Stoddard JN; Maust BS; Deng W; Hural J; Dubey S; Michael NL; Shiver J; Corey L; Li F; Self SG; Kim J; Buchbinder S; Casimiro DR; Robertson MN; Duerr A; McElrath MJ; McCutchan FE; Mullins JI
    Nat Med; 2011 Mar; 17(3):366-71. PubMed ID: 21358627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic architecture of HIV type 1 Nef and Tat from HLA-B57-typed long-term survivors in an Indian cohort of perinatally HIV-infected children.
    Neogi U; Palchaudhuri R; Bommana S; Shet A
    AIDS Res Hum Retroviruses; 2013 Dec; 29(12):1613-6. PubMed ID: 24020900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural defects and variations in the HIV-1 nef gene from rapid, slow and non-progressor children.
    Casartelli N; Di Matteo G; Argentini C; Cancrini C; Bernardi S; Castelli G; Scarlatti G; Plebani A; Rossi P; Doria M
    AIDS; 2003 Jun; 17(9):1291-301. PubMed ID: 12799550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH.
    Malm M; Rollman E; Ustav M; Hinkula J; Krohn K; Wahren B; Blazevic V
    Viral Immunol; 2005; 18(4):678-88. PubMed ID: 16359234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients.
    Calarota S; Bratt G; Nordlund S; Hinkula J; Leandersson AC; Sandström E; Wahren B
    Lancet; 1998 May; 351(9112):1320-5. PubMed ID: 9643795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroviral vectors for HIV immunotherapy.
    Warner JF; Jolly D; Mento S; Galpin J; Haubrich R; Merritt J
    Ann N Y Acad Sci; 1995 Nov; 772():105-16. PubMed ID: 8546383
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.